NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)
Close on Nov 17, 2026Market cap $1.97BP/E –Yield –
NeoGenomics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NeoGenomics's enterprise value was $2.38B on Nov 11, 2026, against $1.40B a year earlier. Over the last 5 years it ranged from $275.05M to $4.19B, with a median of $1.47B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.38B | +76.2% |
| 2025 | Dec 31, 2025 | $1.35B | -22.7% |
| 2024 | Dec 31, 2024 | $1.75B | -0.3% |
| 2023 | Dec 29, 2023 | $1.75B | +94.0% |
| 2022 | Dec 30, 2022 | $903.31M | -78.5% |
| 2021 | Dec 31, 2021 | $4.19B | -28.4% |
| 2020 | Dec 31, 2020 | $5.86B | +96.9% |
| 2019 | Dec 31, 2019 | $2.98B | +155.6% |
| 2018 | Dec 31, 2018 | $1.16B | +44.7% |
| 2017 | Dec 29, 2017 | $804.72M | +15.5% |
| 2016 | Dec 30, 2016 | $696.60M | +57.3% |
| 2015 | Dec 31, 2015 | $442.95M | +100.5% |
| 2014 | Dec 31, 2014 | $220.92M | +28.2% |
| 2013 | Dec 31, 2013 | $172.31M | +56.3% |
| 2012 | Dec 31, 2012 | $110.23M | +91.0% |
| 2011 | Dec 30, 2011 | $57.70M | – |
See a number that looks wrong?